SCHENKEIN DAVID P received a stock award from REGENERON PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2025ACC: 0001968202-25-000012
Director
Since Sep 2023
+2.12K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+166.00
Price / share
—
Trade value
—
% of position
58.9%
1/2/2025
282.00→448.00
Total
Net shares
+166.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | A · Award | +166.00 | — | — | 58.9% | 282.00 | 448.00 |
| Total | +166.00 | $0.00 | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
1.96K shares
Shares
+1.96K
Strike price
719.37
Held after
1.96K
Exercisable
—
1/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.96K shares | 1/2/2025 | A · Award | +1.96K | 719.37 | — | 1.96K |